1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
CT - 278
Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial
Poster Presenter
Authors
Part of Topic
Cellular Therapy (CT)
Overall and progression-free survival in patients with Epstein-Barr virus–driven post-transplant lymphoproliferative disease (EBV+ PTLD) following tabelecleucel treatment: Results from the phase 3 ALLELE trial

